NVAX
Novavax, Inc.
4.09
+
0.14
3.54%
11 x 4.06
11 x 4.09
bid
ask
11 @ 04:00 PM
4.09+0.00 (0.00%)
Bearish
191
Bullish
417
sentiment
3.92
day range
4.13
3.76
52 week range
9.74
Prev Close3.95
Open3.97
Low3.92
High4.13
Volume3.01M
Avg. Volume7.13M
Market Cap572.41M
Inst. Own57.43%
Beta1.60
Short Ratio10.22
Div & Yield0.00 /
EPS-5.41
P/E0.00
1yr Target15.40
50day MA4.69
200day MA6.02
CNQ.TO
Canadian Natural Resources Limited
106.52
04:00 PM
+
0.84
0.79%
G.TO
Augusta Gold Corp.
0.96
03:59 PM
-
0.07
6.80%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.25
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2533.05
05:59 AM
-
46.55
1.80%
600690.SS
Haier Smart Home Co., Ltd.
28.35
03:00 AM
-
0.08
0.28%
0700.HK
Tencent Holdings Limited
348.40
04:08 AM
+
9.00
2.65%
1101.TW
Taiwan Cement Corp.
31.80
01:30 AM
-
0.20
0.62%
20MICRONS.NS
20 Microns Limited
162.85
05:59 AM
+
5.90
3.76%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Novavax Inc. stock outperforms competitors on strong trading day | news.google.com • |
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition | news.google.com • |
NVAX (Novavax) Free Cash Flow | news.google.com • |
Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax Inc. stock underperforms Wednesday when compared to competitors | news.google.com • |
Novavax Inc. stock outperforms competitors on strong trading day | news.google.com • |
Profile
...
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-14 | 2024-03 | -1.04 | N/A | N/A | N/A |
2024-02-28 | 2023-12 | -0.49 | -1.44 | -0.95 | -193.88% |
2023-11-09 | 2023-09 | -1.82 | -1.26 | 0.56 | 30.77% |
2023-08-08 | 2023-06 | -1.24 | 0.58 | 1.82 | 146.77% |
2023-05-09 | 2023-03 | -3.38 | -3.41 | -0.03 | -0.89% |
2023-02-28 | 2022-12 | -0.92 | -2.28 | -1.36 | -147.83% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-08 | B. Riley Securities | Upgrade | Neutral | Buy |
2023-05-09 | HC Wainwright & Co. | Upgrade | Buy | |
2023-02-28 | B. Riley Securities | Downgrade | Buy | Neutral |
2023-02-12 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-01 | HC Wainwright & Co. | Upgrade | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-07 | DUBOVSKY FILIP | Officer | 66.61K | Conversion of Exercise of derivative security |
2023-12-13 | HERRMANN JOHN A III | Officer | 13.23K | Conversion of Exercise of derivative security |
2024-01-22 | JACOBS JOHN C | Chief Executive Officer | 43.10K | Conversion of Exercise of derivative security |
2024-03-07 | KELLY JAMES PATRICK | Chief Financial Officer | 13.29K | Conversion of Exercise of derivative security |
2023-06-08 | MCGLYNN MARGARET G | Director | 3.80K | Conversion of Exercise of derivative security |
2023-06-08 | MOTT DAVID M | Director | 43.80K | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | State Street Corporation | 11.68M | 86.78M | 12.37% |
2023-06-29 | Vanguard Group Inc | 10.57M | 78.55M | 11.20% |
2023-06-29 | Blackrock Inc. | 6.99M | 51.97M | 7.41% |
2023-09-29 | Shah Capital Management | 6.33M | 45.83M | 6.71% |
2023-06-29 | Bank of America Corporation | 2.18M | 16.23M | 2.31% |
2023-06-29 | Morgan Stanley | 2.08M | 15.46M | 2.20% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 9.38M | 75.07M | 9.94% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.64M | 19.60M | 2.79% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.23M | 16.56M | 2.36% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 16.10M | 2.13% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 1.28M | 9.48M | 1.35% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.21M | 8.98M | 1.28% |
Split
...
Split | Date |
---|---|
1 : 20 | 2019-05-10 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
news.google.com • -
NVAX (Novavax) Free Cash Flow
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock underperforms Wednesday when compared to competitors
news.google.com • -
Novavax Inc. stock outperforms competitors on strong trading day
news.google.com • -
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
news.google.com • -
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
news.google.com • -
NVAX Stock Price and Chart — NASDAQ:NVAX
news.google.com • -
Better Buy: Bluebird Bio Vs. Novavax
fool.com • -
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
marketbeat.com • -
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
investorplace.com • -
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
investorplace.com • -
It's Time! 3 Failing Biotech Stocks to Sell Right Now
investorplace.com • -
Exit Alert: 3 Overhyped Stocks With Weak Fundamentals
investorplace.com • -
Is Novavax a Buy Now?
fool.com • -
Novavax sheds a quarter of value as sales look to remain pressured
proactiveinvestors.com • -
Novavax Stock on Track for Worst Day Since 2022
schaeffersresearch.com • -
NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today
investorplace.com • -
Has Novavax Just Solved Its Biggest Problem?
fool.com • -
NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute
investorplace.com • -
Better Bull Market Buy: Novavax vs. Pfizer
fool.com • -
Exit Now! 3 Biotech Stocks to Sell in February 2024
investorplace.com • -
Where Will Novavax Be in 10 Years?
fool.com • -
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
investorplace.com • -
Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts
investorplace.com • -
Novavax to cut 12% of global workforce
reuters.com • -
Is It Too Late to Buy Novavax Stock?
fool.com • -
Where Will Novavax Be in 5 Years?
fool.com • -
Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold
investorplace.com • -
Time to Buy These 3 Stocks That Just Hit a 52-Week Low?
investorplace.com • -
Smart Shorts: 7 Meme Stocks to Bet Against in 2024
investorplace.com • -
3 Heavily Shorted Stocks That Still Won't See a Squeeze
investorplace.com • -
3 Meme Stocks That Could Fade Away in 2024
investorplace.com • -
Is Novavax Stock a Buy Now?
fool.com • -
3 Short-Squeeze Stocks That Could Take Off Before Year-End
investorplace.com • -
Where Will Novavax Be in 3 Years?
fool.com • -
Novavax, Inc. (NVAX) Q3 2023 Earnings Call Transcript
seekingalpha.com • -
Novavax shares rise as third quarter results top expectations
marketwatch.com • -
7 Dangerous Stocks to Avoid No Matter What
investorplace.com • -
Novavax Maintains Covid-19 Shot Rollout Optimism
schaeffersresearch.com • -
Is Novavax Stock a Buy Now?
fool.com • -
Novavax (NVAX) Stock Slides Despite Vaccine Availability
investorplace.com • -
Novavax's COVID-19 Investment Thesis Is Old News
seekingalpha.com • -
3 Pharma Stocks to Dump Before the Damage Is Done
investorplace.com • -
This Could be Novavax's Big Opportunity
fool.com • -
Novavax updated COVID vaccine gets FDA approval
marketwatch.com • -
US FDA authorizes Novavax's updated COVID shot
reuters.com •